Arzerra ofatumumab regulatory update

Genmab and partner GlaxoSmithKline announced the submission of an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for Arzerra ofatumumab to treat chronic lymphocytic leukemia (CLL). GSK, w...